Randomized assessment of rapid endovascular treatment of ischemic stroke. The ESCAPE Trial Investigators. N Engl J Med.

Indu Kapoor

doi:10.4103/2348-0548.155472

Journal of Neuroanaesthesiology and Critical Care, Table of Contents

CC-BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2015; 02(02): 149-150
DOI: 10.4103/2348-0548.155472

Journal Club

Thieme Medical and Scientific Publishers Private Ltd.

Randomized assessment of rapid endovascular treatment of ischemic stroke. The ESCAPE Trial Investigators. N Engl J Med.

Authors

Indu Kapoor

¹Department of Neuroanaesthesiology, All India Institute of Medical Sciences, New Delhi, India

Abstract

Full Text

References

REFERENCES
1 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-7
2 Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E. et al. Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomized trials. Lancet 2014; 384: 1929-35
3 Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD. et al. Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after in-travenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-903
4 Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ. et al. MR CLEAN Investigators. A randomized trial of intra-arterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11-20
5 Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C. et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003-11
6 Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG. et al. SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): A randomized, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241-9
7 Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA. et al. TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularization of large vessel occlusions in acute ischaemic stroke (TREVO 2): A randomized trial. Lancet 2012; 380: 1231-40
8 Demchuk AM, Goyal M, Menon BK, Eesa M, Ryckborst KJ, Kamal N. et al. ESCAPE Trial Investigators. Endovascular treatment for Small Core and Anterior circulation proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial: Methodology. Int J Stroke 2015; 10: 429-38
9 Bayley M, Lindsay P, Hellings C, Hill M, Woodbury E, Phillips S. Canadian Stroke Strategy (a joint initiative of the Canadian Stroke Network and the Heart and Stroke Foundation of Canada). Balancing evidence and opinion in stroke care: the 2008 best practice recommendations. CMAJ 2008; 179: 1247-9
10 Jauch EC, Saver JL, Adams Jr HP, Bruno A, Connors JJ, Demaerschalk BM. et al. American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947
11 Hong KS, Saver JL. Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke 2009; 40: 3828-33
12 Bradley EH, Curry LA, Webster TR, Mattera JA, Roumanis SA, Radford MJ. et al. Achieving rapid door-to-balloon times: How top hospitals improve complex clinical systems. Circulation 2006; 113: 1079-85
13 Krumholz HM, Herrin J, Miller LE, Drye EE, Ling SM, Han LF. et al. Improvements in door-to-balloon time in the United States, 2005 to 2010. Circulation 2011; 124: 1038-45